|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Activation of the JAK-STAT pathway by reactive oxygen species 显示文摘 | Simon AR Rai U Fanburg BL Cochran BH | 1998 | Am J Physiol Cell Physiol1998，275，： | 1 |
| 2 | Circulation time and body distribution of 14C-labeled am in o-modified polystyrene nanoparticles in mice显示文摘 | Simon BH Ando HY Gupta PK | 1995 | J Pharm Sci1995，84，10： | 1 |
| 3 | Pharmacological treatment of coronary artery disease with recombinant fibroblast growth factor-2: double-blind, randomized, controlled clinical trial显示文摘 | Simons M Annex BH Laham RJ | 2002 | Circulation2002，105，7： | 1 |
| 4 | Hypoxia,HIF and the placenta显示文摘 | Fryer BH Simon MC | 2006 | Cell Cycle2006，5，5： | 1 |
| 5 | Pharmacological treatment of coronary artery disease with recombinant fibroblast growth factor-2: double-blind, randomized,controlled clinical trial显示文摘 | Simons M Annex BH Laham R J | 2002 | Crculation2002，105，7： | 1 |
| 6 | Circulation time and body distribution of 14C-labled amino-modified polystyrene nanoparticles in mice显示文摘 | Simon BH Ando HY Cupta PK | 1995 | J Pharm Sci1995，84，10： | 1 |
| 7 | Pharmacological treatment of coronary artery disease with recombinant fibroblast growth factor-2 double-blind, randomized ,controlled clinical trial 显示文摘 | Simons M Annex BH Laham R J | 2002 | Circulation2002，105，： | 1 |
| 8 | Residual tumor cells areunique cellular targets in glioblastoma显示文摘 | Glas M Path BH Simon M | 2010 | Ann Neuro2010，68，2： | 1 |
| 9 | Pharmacological Treatment of Coronary Artery Disease With Recombinant Fibroblast Growth Factor-2 Double-Blind,Randomized,Controlled Clinical Trial显示文摘 | Annex BH Laham RJ | 2002 | Circulation2002，105，7： | 1 |
| 10 | Pharmacological treatment of coronary artery disease with recombinant fibroblast growth factor-2:double-blind,randomized,controlled clinical trial显示文摘 | Simons M Annex BH Laham RJ | 2002 | Circulation2002，105，： | 1 |
| 11 | Hypoxia, HIF and the placenta 显示文摘 | Fryer BH Simon MC | 2006 | Cell Cycle2006，5，5： | 1 |
| 12 | Hypoxia,HIF and the placenta显示文摘 | Fryer BH Simon MC | 2006 | Cell Cycle2006，5，5： | 1 |
| 13 | Pharmacological treatment of coronary artery disease with recombinant fibroblast growth factor-2:double-blind,randomized,controlled clinical trial显示文摘 | Simons M Annex BH Laham RJ Kleiman N Henry T Dauerman H | 2002 | Circulation2002，105，7： | 1 |
| 14 | Pharmacological treatment of coronary artery disease with recombinant fibroblast growth factor-2:double-blind,randomized,controlled clinical trial显示文摘 | Simons M Annex BH Laham RJ | 2002 | Circulation2002，105，： | 1 |
| 15 | Pharmacological treatment of coronary artery disease with recombinant flbroblast growth factor - 2: double-blind, randomized, controlled clinical trial显示文摘 | Simons M Annex BH Laham RJ | 2002 | Circulation2002，105，7： | 1 |
| 16 | Growth factor-induced therapeutic angiogenesis in the heart: protein therapy显示文摘 | Annex BH Simons M | 2005 | Cardiovasc Res2005，65，3： | 1 |
| 17 | Growth factor-induced therapeutic angiogenesis in the heart: protein therapy 显示文摘 | Annex BH Simons M | 2005 | Cardiovasc Res2005，65，3： | 1 |
| 18 | Allyl mercaptan,a major metabolite of garlic compounds,reduces cellular cholesterol synthesis and its secretion in Hep-G2 cells显示文摘 | Shanqin Xu BH Simon Cho | 1999 | J Nutr Biochem1999，10，： | 1 |
| 19 | Growth factor-induced therapeutic angiogenesis in the heart: protein therapy 显示文摘 | Annex BH Simons M | 2005 | Cardiovasc Res2005，65，3： | 1 |
| 20 | Pharma- cotogical treatment of coronary artery disease with recombinant fibroblast growth factor-2: a double-blind, randomized, controlled clinical trial 显示文摘 | Simons M Annex BH Laham R J | 2002 | Circulation2002，105，7： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员